Literature DB >> 21483094

Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.

Eugenio Barone1, Fabio Di Domenico, Giovanna Cenini, Rukhsana Sultana, Raffaella Coccia, Paolo Preziosi, Marzia Perluigi, Cesare Mancuso, D Allan Butterfield.   

Abstract

Biliverdin reductase-A (BVR-A) is a pleiotropic enzyme and plays pivotal role in the antioxidant defense against free radicals as well as in cell homeostasis. Together with heme oxygenase, BVR-A forms a powerful system involved in the cell stress response during neurodegenerative disorders including Alzheimer's disease (AD), whereas due to the serine/threonine/tyrosine kinase activity the enzyme regulates glucose metabolism and cell proliferation. In this paper, we report results that demonstrate BVR-A undergoes post-translational oxidative and nitrosative modifications in the hippocampus, but not cerebellum, of subjects with AD and amnestic mild cognitive impairment (MCI). A significant increase of nitrated BVR-A was demonstrated only in AD and MCI hippocampi, whereas no significant modifications were found in cerebellar tissue. In addition, a significant reduction in protein carbonyl-derivatives of BVR-A was found in both AD and MCI hippocampi (15% and 18%, respectively). Biliverdin reductase-bound 4-hydroxynonenals were not modified in hippocampi and cerebella from AD and MCI subjects. These results supported the hypothesis of a prevalence of nitrosative stress-induced modifications on BVR-A structure, and this evidence was confirmed by a significant upregulation of inducible nitric oxide synthase in hippocampal tissue of subjects with AD and MCI that was not present in cerebellum. In conclusion, nitrosative stress-induced modifications on hippocampal BVR-A are an early event in the pathogenesis of AD since they appear also in MCI subjects and could contribute to the antioxidant and metabolic derangement characteristic of these neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21483094     DOI: 10.3233/JAD-2011-110092

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  35 in total

1.  Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease.

Authors:  Fabio Di Domenico; Gilda Pupo; Cesare Mancuso; Eugenio Barone; Francesca Paolini; Andrea Arena; Carla Blarzino; Frederick A Schmitt; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 2.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

3.  MH84: A Novel γ-Secretase Modulator/PPARγ Agonist--Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer's Disease.

Authors:  Maximilian Pohland; Stephanie Hagl; Maren Pellowska; Mario Wurglics; Manfred Schubert-Zsilavecz; Gunter P Eckert
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

4.  Molecular modeling to provide insight into the substrate binding and catalytic mechanism of human biliverdin-IXα reductase.

Authors:  Gang Fu; Haining Liu; Robert J Doerksen
Journal:  J Phys Chem B       Date:  2012-08-07       Impact factor: 2.991

5.  Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues.

Authors:  Wei Song; Hillel Zukor; Adrienne Liberman; Sagi Kaduri; Zoe Arvanitakis; David A Bennett; Hyman M Schipper
Journal:  Exp Neurol       Date:  2014-01-15       Impact factor: 5.330

6.  Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2018-05-04       Impact factor: 3.478

Review 7.  The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

Authors:  Eugenio Barone; Fabio Di Domenico; Cesare Mancuso; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2013-10-02       Impact factor: 5.996

Review 8.  Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.

Authors:  D Allan Butterfield; Aaron M Swomley; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2013-02-14       Impact factor: 8.401

9.  NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia.

Authors:  Dong-Hee Choi; Kyoung-Hee Lee; Ji-Hye Kim; Ju-Ha Seo; Hahn Young Kim; Chan Young Shin; Jung-Soo Han; Seol-Heui Han; Yoon-Seong Kim; Jongmin Lee
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

Review 10.  Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.

Authors:  Eugenio Barone; Fabio Di Domenico; D Allan Butterfield
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.